338
Participants
Start Date
July 1, 2014
Primary Completion Date
July 1, 2015
Study Completion Date
July 18, 2015
FF
Fluticasone furoate is available as fluticasone furoate inhalation powder (100 mcg per blister), combination of fluticasone furoate/umeclidinium bromide inhalation powder (fluticasone furoate: 100 mcg per blister, umeclidinium bromide: 15.6, 62.5, 125, or 250 mcg per blister) and combination of fluticasone furoate/vilanterol inhalation powder (fluticasone furoate: 100 mcg per blister, vilanterol: 25 mcg per blister)
UMEC
Umeclidinium bromide is available as combination of fluticasone furoate/umeclidinium bromide inhalation powder (fluticasone furoate: 100 mcg per blister, umeclidinium bromide: 15.6, 62.5, 125, or 250 mcg per blister)
VI
Vilanterol is available as vilanterol inhalation powder (25 mcg per blister) and combination of fluticasone furoate/vilanterol inhalation powder (fluticasone furoate: 100 mcg per blister, vilanterol: 25 mcg per blister)
GSK Investigational Site, Kyiv
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Mendoza
GSK Investigational Site, San Rafael
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Morgantown
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Gaffney
GSK Investigational Site, Union
GSK Investigational Site, Greenville
GSK Investigational Site, Rock Hill
GSK Investigational Site, Hanover
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Minneapolis
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Kharkiv
GSK Investigational Site, Kharkiv
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Sunset
GSK Investigational Site, Upland
GSK Investigational Site, San Diego
GSK Investigational Site, Newport Beach
GSK Investigational Site, Medford
GSK Investigational Site, Ploieşti
GSK Investigational Site, Ploieşti
GSK Investigational Site, Moscow
GSK Investigational Site, Piteşti
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Sestroretsk
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Timișoara
GSK Investigational Site, Cluj-Napoca
GSK Investigational Site, Saratov
GSK Investigational Site, Bacau
GSK Investigational Site, Nizhny Novgorod
GSK Investigational Site, Comuna Alexandru Cel Bun
GSK Investigational Site, Blagoveshchensk
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Rosario
GSK Investigational Site, Buenos Aires
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Leipzg
GSK Investigational Site, Teuchern
GSK Investigational Site, Bialystok
GSK Investigational Site, Bialystok
GSK Investigational Site, Katowice
GSK Investigational Site, Kielce
GSK Investigational Site, Lodz
GSK Investigational Site, Poznan
GSK Investigational Site, Sopot
GSK Investigational Site, Zgierz
GSK Investigational Site, Żnin
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Craiova
GSK Investigational Site, Kiev
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY